AAV Zika ORFs

1 to 10 of 15 Items

Page
per page
Set Descending Direction
  1. AAV9-ZIKV-2K
    ZV-2K-AAV9
    pAV-FH
    CMV
    FLAG, His
  2. AAV9-ZIKV-ancC
    ZV-ANC-AAV9
    pAV-FH
    CMV
    FLAG, His
  3. AAV9-ZIKV-C
    ZV-C-AAV9
    pAV-FH
    CMV
    FLAG, His
  4. AAV9-ZIKV-E
    ZV-E-AAV9
    pAV-FH
    CMV
    FLAG, His
  5. AAV9-ZIKV-M
    ZV-M-AAV9
    pAV-FH
    CMV
    FLAG, His
  6. AAV9-ZIKV-NS1
    ZV-NS1-AAV9
    pAV-FH
    CMV
    FLAG, His
  7. AAV9-ZIKV-NS2A
    ZV-NS2A-AAV9
    pAV-FH
    CMV
    FLAG, His
  8. AAV9-ZIKV-NS2B
    ZV-NS2B-AAV9
    pAV-FH
    CMV
    FLAG, His
  9. AAV9-ZIKV-NS3
    ZV-NS3-AAV9
    pAV-FH
    CMV
    FLAG, His
  10. AAV9-ZIKV-NS4A
    ZV-NS4A-AAV9
    pAV-FH
    CMV
    FLAG, His

1 to 10 of 15 Items

Page
per page
Set Descending Direction

To aid Zika virus research, Vigene has cloned and packaged each of the individual 14 Zika virus ORFs into AAV. The Zika ORFs are non-pathogenic and can safely be used for research purposes. Zika virus has gained attention in recent years due to its outbreaks and association with human neurological disorders. There are currently no approved therapies or vaccines, so there is an urgent need to develop strategies that inhibit viral replication. In order to develop these strategies, it is imperative that we gain a better understanding of the function of the proteins involved in the process.